Intravenous immunoglobulins control scleromyxoedema
暂无分享,去创建一个
A. Doria | S. Todesco | S. Jablonska | F. Schiavon | R. Rondinone | M. Cerinic | A. Righi | M. Blasczyk
[1] I. Forgacs,et al. Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg). , 2000, Journal of the American Academy of Dermatology.
[2] M. Kuo,et al. Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[3] Y. Shoenfeld,et al. Skin Score Decrease in Systemic Sclerosis Patients Treated with Intravenous Immunoglobulin – A Preliminary Report , 2000, Clinical Rheumatology.
[4] V. Lennon,et al. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. , 1999, The New England journal of medicine.
[5] A. Pandya,et al. Fatal scleromyxedema: report of a case and review of the literature. , 1998, Journal of the American Academy of Dermatology.
[6] I. Krajnc. [Arndt-Gottron scleromyxedema. Summary of 2 years treatment]. , 1997, Wiener klinische Wochenschrift.
[7] S. Bombardieri,et al. High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience. , 1996, Clinical and experimental rheumatology.
[8] M. Eibl,et al. Immunomodulatory effect of immunoglobulins. , 1996, Clinical and experimental rheumatology.
[9] J. Griffiths,et al. Myeloma associated scleromyxedema with extensive involvement of small bowel , 1991, Pathology.
[10] M. Sanchez,et al. Scleromyxedema Associated with Non‐Hodgkin Lymphoma , 1989, International journal of dermatology.
[11] J. Hunter,et al. Spontaneous resolution of lichen myxoedematosus , 1979, The British journal of dermatology.